Subtilisin-Involved Morphology Engineering for Improved Antibiotic Production in Actinomycetes.

Yuanting Wu,Qianjin Kang,Li-Li Zhang,Linquan Bai
DOI: https://doi.org/10.3390/biom10060851
IF: 6.064
2020-01-01
Biomolecules
Abstract:In the submerged cultivation of filamentous microbes, including actinomycetes, complex morphology is one of the critical process features for the production of secondary metabolites. Ansamitocin P-3 (AP-3), an antitumor agent, is a secondary metabolite produced byActinosynnema pretiosumATCC 31280. An excessive mycelial fragmentation ofA. pretiosumATCC 31280 was observed during the early stage of fermentation. Through comparative transcriptomic analysis, a subtilisin-like serine peptidase encoded geneAPASM_4178was identified to be responsible for the mycelial fragmentation. Mutant WYT-5 with theAPASM_4178deletion showed increased biomass and improved AP-3 yield by 43.65%. We also found that the expression ofAPASM_4178is specifically regulated by an AdpA-like protein APASM_1021. Moreover, the mycelial fragmentation was alternatively alleviated by the overexpression of subtilisin inhibitor encoded genes, which also led to a 46.50 +/- 0.79% yield increase of AP-3. Furthermore,APASM_4178was overexpressed in salinomycin-producingStreptomyces albusBK 3-25 and validamycin-producingS. hygroscopicusTL01, which resulted in not only dispersed mycelia in both strains, but also a 33.80% yield improvement of salinomycin to 24.07 g/L and a 14.94% yield improvement of validamycin to 21.46 g/L. In conclusion, our work elucidates the involvement of a novel subtilisin-like serine peptidase in morphological differentiation, and modulation of its expression could be an effective strategy for morphology engineering and antibiotic yield improvement in actinomycetes.
What problem does this paper attempt to address?